Agenus reported U$185 million in Assets for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Abbvie U$ 149530M 58331M
Acceleron Pharma U$ 479M 15M
Agenus U$ 185.784M 5.729M
Amgen U$ 65011M 3342M
AstraZeneca 59929M 2718M
Bristol Myers Squibb U$ 128076M 1209M
Celldex Therapeutics U$ 261M 149M
CSL 1546460000 139000000
Dicerna Pharmaceuticals U$ 732M 46M
Dynavax Technologies U$ 329M 70M
Eli Lilly And U$ 41967M 864.2M
Genocea Biosciences U$ 40.516M 4.676M
Gilead Sciences U$ 55934M 3807M
GlaxoSmithKline 84640M 258M
Glaxosmithkline U$ 80927M 3713M
Immunogen U$ 269.728M 29.081M
Intrexon U$ 361M 43M
Merck € 43822M 921M
Merk U$ 90615M 5702M
Novavax U$ 932M 604M
Pfizer U$ 177934M 11598M
Regeneron Pharmaceuticals U$ 14428.7M 1328.8M
Stemline Therapeutics U$ 170M 16M
Veracyte U$ 256.737M 10.363M
YTE U$ 3212.321M 459.899M